Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from melanoma

Evaxion Biotech To Test EVX-03 DNA Vaccine For Non-Small Cell Lung Cancer

Evaxion Biotech A/S (NASDAQ:EVAX) has selected EVX-03 as the product candidate within its DNA technology platform to target a new indication with planned regulatory filing in H2 2022. We currently have two product candidates in the DNA technology platform, EVX-02, and EVX-03. Based on preclinical results, the company has decided to move EVX-03…

Benzinga

Skincare experts warn against viral tanning TikTok hack

‘Exposure to the sun with no protection can severely increase the risk of sunburn which can lead to melanoma’

The Independent UK

Aura Biosciences' Belzupacap Sarotalocan At Par With Plaque Radiotherapy In Eye Cancer

Aura Biosciences Inc (NASDAQ:AURA) reported data from a retrospective analysis that assessed the visual acuity after plaque radiotherapy treatment compared with prospective data in early-stage choroidal melanoma patients treated with belzupacap sarotalocan by intravitreal administration in the Phase 1b/2 trial. The vision results of patients with early-stage choroidal melanoma treated with radiotherapy showed…

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Online tool gives hope to cancer patients

An online calculator developed by Australian scientists could help cancer patients know which treatments are best suited for them and ultimately save lives.

Crikey

'Lucky' mum diagnoses own skin cancer after using app to check worrying new mole

Laura O’Donnell had become increasingly concerned after noticing the tiny growth on her stomach just before lockdown, before using an app to determine if the mole was potentially dangerous

Daily Mirror

Scientists Identify Potential Drug Combination to Eliminate Cancer with ‘Killer Cells

Most skin cancer drugs that activate the immune system work by triggering immune cells, called T-cells, to attack tumors, but when T-cells are activated for too long, they can wear out and cease to function. In a new study led by Penn State College of Medicine, scientists found that another…

Asharq Al-Awsat

Scots mum 'diagnosed' own with skin cancer with app from smartphone

Laura O’Donnell had become increasingly concerned after noticing the tiny growthon her stomach just before lockdown.

Daily Record

Read news from The Economist, FT, and more,
with one subscription

Protein molecule link to melanoma outcomes

Melanoma patients who express a specific protein molecule are two-and-a-half times more likely to die within 10 years, South Australian researchers have found.

AAP

Eating fish has been linked to an increase in melanoma risk – but that doesn't mean we should take it off the menu

You wouldn’t expect fish and melanoma to be in the same headline – but they were last week. Researchers in the United States reported a higher risk of developing melanoma, a common type of potentially deadly skin cancer, in people who ate a relatively large amount of fish.

The Conversation

Deadly skin cancer linked to eating two portions of fish per week, study finds

The study suggests eating just two servings a week could increase the risk

Daily Record

Eating fish is linked to deadliest form of skin cancer

Just two portions a week could increase your risk, a study suggests

Wales Online

Eating two portions of fish a week linked to skin cancer, study suggests

US research identifies ‘association that requires further investigation’ – but some scientists aren’t convinced

The Independent UK

Eating two portions of fish per week ‘linked to malignant melanoma’

US experts said their findings warranted investigation while others urged people not to stop eating fish.

The Independent UK

Eating two portions of fish per week linked to increased risk of skin cancer

The findings come from a study of nearly 500,000 participants

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Delcath Systems Stock Jumps After Data Update From Eye Cancer Trials At ASCO Meeting

Delcath Systems Inc (NASDAQ:DCTH) announced further details regarding presentations relating to its proprietary percutaneous hepatic perfusion (PHP) system. The CHOPIN trial assessed ipilimumab plus nivolumab (IPI+NIVO) combined with Delcath's proprietary liver-targeted PHP treatment in metastatic uveal melanoma patients. The poster reports a Best Overall Response of 1 complete response, five partial responses, and…

ABC News

New research finds nearly a third of melanomas found during skin checks may not be harmful, improving treatment options

The discovery means skin checks are still important but paves the way for some "exciting" research possibilities to improve the diagnosis and treatment of the disease.

The Conversation

80% of all cancers are on the skin. What happens if I have one?

Two in three Australians will have a skin cancer in their lifetime, nearly all of them basal cell carcinomas (BCC), squamous cell carcinomas (SCC) or melanomas.

The Conversation

The doctor says my mole is a melanoma. What happens next?

So your doctor removed a mole from your skin and now says it’s cancerous. What happens next?

Get all your
news in one place.

100’s of premium titles.
One news app.

Chronicle Live

County Durham mum whose itchy mole turned out to be skin cancer on how her story is helping others

Gill Liiv-Rochester, 36, from Seaham was diagnosed with two malignant melanomas in 2020

Wales Online

Doctor explains 'red flag' skin cancer signs to watch for on moles

Many don't know what to look out for but early treatment is essential for the best chance of survival

Daily Record

Doctor shares skin cancer 'red flag' signs on moles that could be early melanoma

Experts say the most common areas to develop skin cancer are different in men and women.

Benzinga

CHMP Supports Approval Of Merck's Keytruda As Adjuvant In Post Surgery Melanoma Setting

European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending Merck & Co Inc (NYSE:MRK) Keytruda in melanoma setting. The opinion covers Keytruda as a monotherapy adjuvant treatment for adults and adolescents aged 12 years and older with stage IIB or IIC melanoma and who have…

Benzinga

FDA Places Clinical Hold On Foghorn Therapeutics' Early-Stage Blood Cancer Trial

The FDA has instituted a clinical hold on Foghorn Therapeutics Inc's (NASDAQ:FHTX) Phase 1 dose-escalation study of FHD-286 in relapsed and/or refractory acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS). The FDA initiated the partial clinical hold following the report of a recent death that occurred in a subject with potential differentiation syndrome. Differentiation…

The Guardian - AU

Ban on solariums in England would save hundreds of lives from skin cancer, study finds

Scientists who were instrumental in sunbeds being banned in Australia are helping UK researchers to try to reduce melanoma cases

Benzinga

IO Biotech Starts Dosing In Late-Stage IO102-IO103/Keytruda Combo Trial In Melanoma Patients

IO Biotech (NASDAQ: IOBT) dosed first patient in its phase 3 clinical trial of lead drug candidate, IO102-IO103, in combination with Merck's KEYTRUDA® (pembrolizumab) in patients with previously untreated, unresectable or metastatic (advanced) melanoma.

1 … 9 10 11 12

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

University of Manchester

129 stories

University of Queensland

European Medicines Agency

American Depositary Shares

14 stories

Foghorn

11 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.